Trending Topic

Breast Cancer
29 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Endocrine therapy (ET) has changed the natural history of hormone receptor-positive (HR+) breast cancer (BC) and is the cornerstone of the treatment of HR+ BC. There are several ETs approved for the treatment of BC, including selective oestrogen receptor modulators (SERMs; tamoxifen), aromatase inhibitors (AIs; anastrazole, letrozole and exemestane) and selective oestrogen receptor degraders (SERDs; fulvestrant […]

Mark Lawler, European Cancer Summit 2021: Time To Act: COVID-19 & Cancer Campaign

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Nov 18th 2021

We were delighted to catch up with Prof Mark Lawler to discuss the challenges that the COVID-19 pandemic has had on cancer care in Europe, and the key objectives and messages of the Time To Act: COVID-19 & Cancer campaign.

Questions
1. What has been the impact of the COVID-19 pandemic on cancer screening and care? (00:20-01:55)
2. What are the objectives of the Time to Act campaign? (01:55-03:18)
3. What are the three key messages in this campaign? (03:18-04:38)
4. What resources are available as part of this campaign? (04:38-05:55)

Speaker Disclosure: Prof Mark Lawler has received honoraria from Pfizer, EMD Serono, Roche and Canall Farrar. This funding is unrelated to this work.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Sophie Nickelson.

Filmed in coverage of the European Cancer Summit 2021

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied

This Functionality is for
Members Only

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

Close Popup